# Real-life Use of Cefazolin for the Treatment of Meticillin-susceptible Staphylococcal Infective Endocarditis: Comparison to a Treatment Cohort With Penicillin M

> **NCT05474118** · — · COMPLETED · sponsor: **Centre Hospitalier Annecy Genevois** · enrollment: 192 (actual)

## Conditions studied

- Infectious Disease
- Endocarditis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05474118
- **Lead sponsor:** Centre Hospitalier Annecy Genevois
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-05
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05474118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05474118, "Real-life Use of Cefazolin for the Treatment of Meticillin-susceptible Staphylococcal Infective Endocarditis: Comparison to a Treatment Cohort With Penicillin M". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05474118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*